Patents Assigned to Instytut Biotechnologii I Antybiotykow
-
Patent number: 9585942Abstract: The invention relates to an insulin analogue or its pharmaceutically acceptable salt, pharmaceutical composition with prolonged therapeutic effect, application of the insulin analogue, dosage method and method of treatment of diabetes. In more detail, the solution pertains to compounds being stable insulin analogues which are pharmaceutically active and characterized by a prolonged, flat, truly peakless course of glucose concentration vs. time during repeated administration and which do not show strong 24 hours fluctuations of glucose concentration, or the so-called “sawteeth effect”, during this time. Results of studies of compounds included in the scope of this application indicate an improvement in the effects of diabetes treatment by avoiding the hitherto occurring adverse influence of changes in glucose concentration throughout the entire day on a patient's organism, e.g.Type: GrantFiled: May 22, 2013Date of Patent: March 7, 2017Assignee: Instytut Biotechnologii i AntybiotykowInventors: Piotr Borowicz, Andrzej Płucienniczak, Jerzy Mikołajczyk, Jarosław Antosik, Jacek Pstrzoch, Justyna Bernat, Diana Mikiewicz-Syguła, Monika Bogiel, Dorota Stadnik, Graźyna Płucienniczak, Boźena Tejchman-Małecka, Tadeusz Głąbski, Iwona Sokołowska, Dariusz Kurzynoga, Anna Wojtowicz-Krawiec, Marcin Zieliński, Malgorzata Kęsik-Brodacka, Natalia Łukasiewicz, Violetta Cecuda-Adamczewska, Monika Pawłowska, Tomasz Pawlukowiec, Jacek Stępniewski
-
Publication number: 20150164998Abstract: The invention relates to an insulin analogue or its pharmaceutically acceptable salt, pharmaceutical composition with prolonged therapeutic effect, application of the insulin analogue, dosage method and method of treatment of diabetes. In more detail, the solution pertains to compounds being stable insulin analogues which are pharmaceutically active and characterised by a prolonged, flat, truly peakless course of glucose concentration vs. time during repeated administration and which do not show strong 24 hours fluctuations of glucose concentration, or the so-called “sawteeth effect”, during this time. Results of studies of compounds included in the scope of this application indicate an improvement in the effects of diabetes treatment by avoiding the hitherto occurring adverse influence of changes in glucose concentration throughout the entire day on a patient's organism, e.g.Type: ApplicationFiled: May 22, 2013Publication date: June 18, 2015Applicant: INSTYTUT BIOTECHNOLOGII I ANTYBIOTYKOWInventors: Piotr Borowicz, Andrzej Plucienniczak, Jerzy Mikolajczyk, Jaroslaw Antosik, Jacek Pstrzoch, Justyna Bernat, Diana Mikiewicz-Sygula, Monika Bogiel, Dorota Stadnik, Grazyna Plucienniczak, Bozena Tejchman-Malecka, Tadeusz Glabski, Iwona Sokolowska, Dariusz Kurzynoga, Anna Wojtowicz-Krawiec, Marcin Zielinski, Malgorzata Kesik-Brodacka, Natalia Lukasiewicz
-
Publication number: 20140121353Abstract: New biosynthetic analogues of recombined human insulin of prolonged therapeutical activity, which can find place in prophylactic and treatment of diabetes.Type: ApplicationFiled: November 26, 2013Publication date: May 1, 2014Applicant: INSTYTUT BIOTECHNOLOGII I ANTYBIOTYKOWInventors: Piotr BOROWICZ, Andrzej PLUCIENNICZAK, Jerzy MIKOLAJCZYK, Tadeusz GLABSKI, Dariusz KURZYNOGA, Diana MIKIEWICZ-SYGULA, Anna WOJTOWICZ-KRAWIEC, Marcin ZIELINSKI, Malgorzata KESIK-BRODACKA, Violetta ADAMCZEWSKA-CECUDA, Iwona SOKOLOWSKA, Grazyna PLUCIENNICZAK, Dorota STADNIK, Jaroslaw ANTOSIK, Jacek PSTRZOCH, Justyna BERNAT, Wojciech SLAWINSKI, Tomasz PAWLUKOWIEC, Jacek STEPNIEWSKI, Monika BOGIEL
-
Patent number: 8628954Abstract: The subject matters of invention relate to expression cassette, use of the expression cassette, vector, host cell, a method for producing a polypeptide ensuring its stable expression by the prokaryotic host as well as an use of the expression cassette. The invention enables stable expression of the target polypeptide, in systems where DNA-dependent RNA polymerase recognizes promoter regulating synthesis of target protein as well as selection marker, which is required for survival of the host.Type: GrantFiled: June 8, 2007Date of Patent: January 14, 2014Assignee: Instytut Biotechnologii I AntybiotykowInventors: Andrzej Plucienniczak, Malgorzata Kesik, Grazyna Plucienniczak, Diana Mikiewicz-Sygula
-
Patent number: 8618048Abstract: New biosynthetic analogues of recombined human insulin of prolonged therapeutical activity, which can find place in prophylactic and treatment of diabetes.Type: GrantFiled: July 4, 2009Date of Patent: December 31, 2013Assignee: Instytut Biotechnologii I AntybiotykówInventors: Piotr Borowicz, Andrzej Plucienniczak, Jerzy Mikolajczyk, Tadeusz Glabski, Dariusz Kurzynoga, Diana Mikiewicz-Sygula, Anna Wojtowicz-Krawiec, Marcin Zielinski, Malgorzata Kesik-Brodacka, Violetta Adamczewska-Cecuda, Iwona Sokolowska, Grazyna Plucienniczak, Dorota Stadnik, Jaroslaw Antosik, Jacek Pstrzoch, Justyna Bernat, Wojciech Slawinski, Tomasz Pawlukowiec, Jacek Stepniewski, Monika Bogiel
-
Patent number: 8158382Abstract: Invention relates to novel and improved UBP1 protease mutants with a substitution at position (754), a deletion of amino-acids at position (1-54) and at least a portion of the amino-acids found at position (55-98) and their coding sequence as well as their applications and heterogonous protein expression system comprising thereof.Type: GrantFiled: January 10, 2005Date of Patent: April 17, 2012Assignee: Instytut Biotechnologii I AntybiotykowInventors: Andrzej Plucienniczak, Anna Wojtowicz, Anna Mazurkiewicz, Luiza Chojnacka
-
Publication number: 20110136736Abstract: New biosynthetic analogues of recombined human insulin of prolonged therapeutical activity, which can find place in prophylactic and treatment of diabetes.Type: ApplicationFiled: July 4, 2009Publication date: June 9, 2011Applicant: INSTYTUT BIOTECHNOLOGII I ANTYBIOTYKOWInventors: Piotr Borowicz, Andrzej Plucienniczak, Jerzy Mikolajczyk, Tadeusz Glabski, Dariusz Kurzynoga, Diana Mikiewicz-Sygula, Anna Wojtowicz-Krawiec, Marcin Zieelinski, Malgorzata Kesik-Brodacka, Violetta Adamczewska-Cecuda, Iwona Sokolowska, Grazyna Plucienniczak, Dorota Stadnik, Jaroslaw Antosik, Jacek Pstrzoch, Justyna Bernat, Wojciech Slawinski, Tomasz Pawlukowiec, Jacek Stepniewski, Monika Bogiel
-
Patent number: 7892787Abstract: A method of producing somatotropin encompassing the microbiological expression of a recombinant protein containing somatotropin and hybrid polypeptide containing the amino-acid sequence of ubiquitin and the amino-acid sequence of somatotropin.Type: GrantFiled: July 7, 2006Date of Patent: February 22, 2011Assignee: Instytut Biotechnologii I AntybiotykowInventors: Andrzej Plucienniczak, Maria Ludwika Smorawinska, Renata Wolinowska, Diana Mikiewicz-Sygula, Iwona Sokolowska, Natalia Lukasiewicz, Luiza Chojnacka, Grazyna Plucienniczak, Jolanta Kuthan-Styczen, Krystyna Strzezek, Alina Marciniak-Rusek, Anna Kruszynska, Anna Wojtowicz, Anna Mazurkiewicz-Pisarek, Ewa Wojcik
-
Patent number: 7868148Abstract: A method is described of obtaining a plasmid contained in a difficult to separate, heterogenous plasmid DNA fraction, particularly one containing various plasmids of similar sizes. Another aspect of the present invention are new plasmids obtained via the method according to the present invention, their derivatives and/or fragments, as well as the application of these products in biotechnology and medicine, particularly gene therapy.Type: GrantFiled: July 7, 2006Date of Patent: January 11, 2011Assignee: Instytut Biotechnologii I AntybiotykowInventors: Andrzej Plucienniczak, Maria Ludwika Smorawinska, Renata Wolinowska, Diana Mikiewicz-Sygula, Agata Jagiello, Radoslaw Kaczanowski, Luiza Chojnacka, Grazyna Plucienniczak, Ewa Zielinska, Krystyna Strzezek, Alina Marciniak-Rusek
-
Publication number: 20100297773Abstract: The subject matters of invention relate to expression cassette, use of the expression cassette, vector, host cell, a method for producing a polypeptide ensuring its stable expression by the prokaryotic host as well as an use of the expression cassette. The invention enables stable expression of the target polypeptide, in systems where DNA-dependent RNA polymerase recognises promoter regulating synthesis of target protein as well as selection marker, which is required for survival of the host.Type: ApplicationFiled: June 8, 2007Publication date: November 25, 2010Applicant: INSTYTUT BIOTECHNOLOGII I ANTYBIOTYKOWInventors: Andrzej Plucienniczak, Malgorzata Kesik, Grazyna Plucienniczak, Diana Mikiewicz-Sygula
-
Publication number: 20090298786Abstract: A method of treating hepatitis C viral infection or viremia in a patient by administering to the patient an anti-hepatitis C virally effective amount of a compound of Formula 1 or Formula 2. A method for inhibiting the replication of hepatitis C virus by exposing the virus to a hepatitis C viral NS3 protease inhibiting amount of: a compound of Formula 1 or Formula 2. A pharmaceutical composition exhibiting an antihelicase activity containing at least a pharmaceutically-acceptable carrier, diluent or excipient, and a compound of Formula 1 or Formula 2. The pharmaceutical composition may additionally contain a second compound of Formula 1 or Formula 2; epidoxorubicin, doxorubicin, epidaunorubicin, or daunorubicin; and/or another antiviral agent.Type: ApplicationFiled: August 7, 2009Publication date: December 3, 2009Applicants: INSTYTUT BIOTECHNOLOGII I ANTYBIOTYKOW, INSTYTUT BIOCHEMII I BIOFIZYKI POLSKIEJ AKADEMII NAUKInventors: Irena OSZCZAPOWICZ, Anna BOGUSZEWSKA-CHACHULSKA, Mariusz KRAWCZYK, Malgorzata LUKAWSKA